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Abstract: Total fatty acid analysis is a routine method in many areas, including lipotyping of
individuals in personalized medicine, analysis of foodstuffs, and optimization of oil production
in biotechnology. This analysis is commonly done by converting fatty acyl (FA) chains of intact
lipids into FA methyl esters (FAMEs) and monitoring these by gas-chromatography (GC)-based
methods, typically requiring at least 15 min of analysis per sample. Here, we describe a novel method
that supports fast, precise and accurate absolute quantification of total FA levels in human plasma
and serum samples. The method uses acid-catalyzed transesterification with 18O-enriched H2O
(i.e., H218O) to convert FA chains into 18O-labeled free fatty acids. The resulting “mass-tagged”
FA analytes can be specifically monitored with improved signal-to-background by 1 min of high
resolution Fourier transform mass spectrometry (FTMS) on an Orbitrap-based mass spectrometer.
By benchmarking to National Institute of Standards and Technology (NIST) certified standard
reference materials we show that the performance of our method is comparable, and at times
superior, to that of gold-standard GC-based methods. In addition, we demonstrate that the
method supports the accurate quantification of FA differences in samples obtained in dietary
intervention studies and also affords specific monitoring of ingested stable isotope-labeled fatty
acids (13C16-palmitate) in normoinsulinemic and hyperinsulinemic human subjects. Overall, our
novel high-throughput method is generic and suitable for many application areas, spanning basic
research to personalized medicine, and is particularly useful for laboratories equipped with high
resolution mass spectrometers, but lacking access to GC-based instrumentation.
Keywords: total fatty acid analysis; human blood plasma; shotgun lipidomics; high resolution mass
spectrometry; Orbitrap
1. Introduction
Total fatty acyl (FA) analysis of human blood samples (i.e., lipotyping) is important for the
diagnosis of essential fatty acid deficiency [1] and inborn errors of fatty acid metabolism [2],
for lipid-based risk stratification at the population-level, and for monitoring the metabolic health of
individuals [3–6]. Moreover, total FA analysis is also in widespread use in other fields of research,
including optimization of oil production by microorganisms and plants [7,8], and monitoring the
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composition of foods [9]. These application areas typically require a high sample throughput,
which inherently benefit from simple, high-throughput routines supporting accurate, precise, and
absolute quantification of total FA levels.
Total FA analysis is typically carried out using gas-chromatography (GC)-based methods.
The underlying methodology is straightforward and involves using either acid- or base-catalyzed
reactions to convert FA chains of intact lipids and non-esterified fatty acids into volatile FA methyl ester
(FAME) species that can be detected using GC coupled to a flame ionization detector (GC-FID) [10,11]
or a mass spectrometer (GC-MS) [10–13]. By using different chromatographic parameters (incl. column
materials, gradients) and detection principles, it is possible to monitor FA analytes at different levels of
structural resolution, which typically scales with increased analysis time and technical diligence of the
operator [13,14]. As such, total FA analysis ranges from the identification of the total number of acyl
carbon atoms and double bonds (e.g., FA 18:1), requiring about 15 min of analysis per sample, to the
separation of distinct FA isomers having different positions and configurations of double bonds (e.g., FA
18:1(9Z) and FA 18:1(11E)), requiring up to 125 min of analysis [13]. Thus, the downside of increasing
structural resolution is a significant increase in analysis time. Another potential downside of GC-based
approaches is that accurate quantification requires multiple isotope-labeled internal standards (isotope
dilution method) as well as generation of multiple calibration curves [13,14]. Notably, in clinical
settings, and in other application areas, one needs to strike a unique balance between the analysis time,
the depth of structural resolution, and the required sample throughput.
Total FA analysis can also be performed by electrospray ionization-based methods coupled to
upfront liquid chromatography (i.e., LC-MS) or by direct infusion (shotgun) MS. Although GC-MS
is considered the gold-standard method for total FA analysis, the detection capabilities and analysis
time of LC-MS-based methods parallel those of GC-MS. Samples require chemical derivatization,
or hydrolysis to free fatty acids, but the methodology can be highly sensitive [15] and support
metabolic flux analysis [16]. More recently, a method for total FA analysis using multiplexed isobaric
tagging and 40 min of LC-MS was described [17]. Although the structural resolution provided by this
method is no match to that of GC-MS (only identification of total number of carbon atoms and double
bonds), the potential multiplexing of up to ten samples drives this approach towards high-throughput.
FA analysis by direct infusion (shotgun) MS is also relatively simple and fast, and, in comparison
to GC- and LC-based approaches, devoid of any sample carry-over when using automated chip-based
sprayers for injecting individual samples [18]. Various derivatization methods for analyzing
non-esterified fatty acids by direct infusion MS have been developed [19,20]. These methods, however,
are not directly applicable for monitoring the composition of esterified FA analytes derived from intact
lipid molecules. Nevertheless, a particular virtue of these methods is that they enable MS/MS-based
structural characterization of double bond positions. We have recently used high resolution Fourier
transform mass spectrometry (FTMS) in negative ion mode for the detection of non-esterified fatty
acids as carboxylate anions and quantification of these in a larger cohort of plasma samples [21].
This work suggested that negative ion mode FTMS analysis could also be used for total FA analysis,
and potentially be faster and more sensitive than most high throughput-based GC and LC methods.
Here, we describe a novel method for the quantification of total FA levels in human plasma
and serum samples. The method uses acid-catalyzed hydrolysis of intact lipids in the presence of
18O-enriched water (i.e., H218O). This reaction yields 18O-labeled free fatty acid species that can be
specifically detected and quantified by automated high resolution FTMS analysis on an Orbitrap-based
instrument coupled to a chip-based nanoelectrospray ionization source. Notably, the reaction can be
carried out directly with diluted plasma and serum without prior lipid extraction, thereby bypassing
potential biases deriving from sample extraction. We show that (i) negative ion mode analysis of
deprotonated FA analytes is exceptionally sensitive, (ii) quantitative analysis can be performed in
only 1 min, (iii) the method is accurate and precise, and (iv) that high resolution FTMS analysis with
a resolving power above 400,000 (full width at half maximum, FWHM) affords baseline separation of
13C, 2H, and 18O isotopologues, which offers a new analytical avenue for metabolic flux analysis.
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This method is generic and will be useful for laboratories equipped with high resolution mass
spectrometers, but lacking access to GC-based instrumentation, and for quantifying total FA levels in a
variety of biological sample matrices.
2. Materials and Methods
2.1. Chemicals and Standards
Acetonitrile, n-hexane, methanol, 2-propanol, and water were purchased from Biosolve BV
(Valkenswaard, The Netherlands). Chloroform was from Rathburn Chemicals (Walkerburn, UK).
Ammonium formate was from Sigma-Aldrich (Buchs, Switzerland). All solvents and chemicals were
HPLC grade. Sulfuric acid and butylated hydroxytoluene (BHT) were from Sigma-Aldrich (Steinheim,
Germany), 18O-labeled water (i.e., H218O) was from Medical Isotopes (Pelham, NH, USA). Lipid
standards PE 15:0/18:1(+2H7) (1-pentadecanoyl-2-oleoyl(d7)-sn-glycero-3-phosphoethanolamine) and
LPC 16:0(+2H3) (1-palmitoyl-d3-sn-glycero-3-phosphocholine) were obtained from Avanti Polar Lipids
(Alabaster, AL, USA). A FAME standard mixture, with equal amounts of FAME 16:0, 18:0, 16:1, 18:1,
18:2, 18:3n−3, 18n−6, 20:3, 20:4, 20:5, 22:4, 22:5n−3, 22:5n−6 and 22:6, was obtained from Larodan
Fine Chemicals (Solna, Sweden).
2.2. Human Plasma Samples
National Institute of Standards and Technology (NIST) Standard Reference Material (SRM) 1950
and 2378 were used for validation. In short, SRM 1950 was collected from 100 fasted individuals in
the age range of 40–50 years and represents the plasma average composition of the US population as
defined by race, sex, and health. SRM 2378 consists of 3 serum materials collected from: (1) donors
who did not take either fish or flaxseed oil supplements for one month prior to collection, (2) donors
who took flaxseed oil supplements for a minimum of one month prior to collection, and (3) donors
who took fish oil supplements for a minimum of one month prior to collection.
Plasma samples from five normoinsulinemic and five hyperinsulinemic subjects were obtained as
previously described [22]. In short, after an overnight fast the subjects had a cannula inserted into an
antecubital vein, and baseline (0 h) blood plasma samples were taken. Subjects were then fed a mixed
meal containing 200 mg of 13C16-labeled palmitic acid (FA 16:0(+13C16)). Another blood plasma sample
was taken after 6 h, shown previously to yield the highest incorporation of FA 16:0(+13C16) into plasma
triacylglycerols [22]. The study was approved by Portsmouth Clinical Research Ethics Committee
(REC 12/SC/0267), and all subjects gave written informed consent. The study was performed in
accordance with the Helsinki Declaration.
2.3. Sample Preparation
Plasma and serum, 15 µL, were mixed with 210 µL of 155 mM ammonium formate. Fifteen µL
of this mixture (equivalent to 1 µL of undiluted blood sample) was transferred into a 1.1 mL glass
vial (La-Pha-Pack GmbH) with 7 µL of 162.3 µM PE 15:0/18:1(+2H7) added as internal standard, and
vacuum evaporated. Next, the sample was dissolved in 80 µL of freshly prepared 0.75 M H2SO4 in
acetonitrile/H218O (9:1, v/v) containing 50 µg/mL BHT. For hydrolysis, the sample was placed in
a ThermoMixer (Eppendorf, Wesseling-Berzdorf, Germany) for 5 h at 90 ◦C and 750 rpm. After cooling,
fatty acids were extracted with 180 µL of n-hexane by mixing for 10 min at 1400 rpm and centrifugation
for 5 min at 1000 g. The fatty acid extraction with n-hexane was repeated, and the combined extracts
were vacuum evaporated.
2.4. Mass Spectrometric Analysis
The total FA extracts were dissolved in 500 µL chloroform/methanol/2-propanol (1:2:4, v/v/v)
containing 0.75 mM ammonium formate and loaded in a 96-well plate (Eppendorf, Hamburg,
Germany). Ten µL of each fatty acid extract was infused using the robotic nanoflow ion source
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TriVersa NanoMate (Advion Biosciences, Ithaca, NY, USA) and analyzed in negative ion mode using
an Orbitrap Fusion Tribrid mass spectrometer (Thermo Fisher Scientific, San Jose, CA, USA). Ionization
voltage was −0.96 kV and back pressure was 1.25 psi. The temperature of the ion transfer tube was
275 ◦C. S-lens radio frequency level was set to 60%. Negative ion mode FTMS analysis was performed
in m/z range 150–420. Each sample was analyzed for 1 min. All full scan FTMS data were acquired in
profile mode, using a max injection time of 100 ms, automated gain control for an ion target of 105,
three microscans (to reduce file size), and a target resolution setting of 500,000.
2.5. Lipid Identification and Quantification
Carboxylate anions of 18O-labeled and unlabeled (16O) FA analytes detected by FTMS analysis
with a mass accuracy better than±2.5 ppm were identified and quantified using ALEX123 software [23].
FA species were quantified by summing the intensities of doubly (18O2) and singly (16O18O) tagged
FA analytes, normalizing to the sum intensity of doubly (18O2) and singly (16O18O) tagged internal
standard FA 18:1(+2H7), and multiplying by the spike amount of PE 15:0/18:1(+2H7). To minimize
bias from FA-contaminants present in reagents and other materials (see below), a blank correction was
performed by subtracting the average amount of FA detected in reaction blanks from the amounts
quantified in the samples. Statistical analysis, paired and unpaired t-tests, was performed using SAS
9.3 (SAS Institute, Cary, NC, USA).
2.6. FAME Analysis
Human plasma and a reaction blank were analyzed as previously described [24]. Briefly, samples
were derivatized using methanolic acetylchloride in n-hexane, and FAMEs were extracted using
potassium carbonate in water. The total FAME extracts were analyzed by GC-MS using a total run
time of 15 min.
3. Results and Discussion
3.1. Total Fatty Acyl Analysis by Direct Infusion FTMS Analysis
The aim of the current study was to develop a method that supports fast, precise, and accurate
absolute quantification of total FA levels in human blood plasma and serum samples using
direct infusion-high resolution FTMS analysis. To this end, we adapted the acid-catalyzed
transesterification-based protocol commonly used for total FA analysis by GC-based approaches
to generate free fatty acids instead of FAMEs. This was achieved by substituting methanol with
H2O (see Materials and Methods for details). The rationale for this design was that negative ion
mode analysis of deprotonated fatty acids (i.e., [M-H]−) is highly sensitive, and that quantitative
analysis of intact lipids by direct infusion FTMS can be performed using only a few minutes of
analysis per sample [25–27]. Through meticulous method optimization we devised a method that
uses only 1 µL of human plasma or serum, instead of 10–50 µL plasma as required by gold-standard
GC-MS-based routines [13,24]. For total FA analysis, the 1 µL of plasma or serum is spiked with a
defined amount of internal standard (e.g., PE 15:0/18:1(+2H7)), followed by evaporating the sample to
dryness, hydrolyzing intact lipids using sulfuric acid (H2SO4) in acetonitrile/H2O (9:1, v/v), extracting
the free fatty acids with hexane, and analyzing (2% of) the final total FA extract by 1 min of automated
direct infusion-high resolution FTMS analysis. Using this approach, in conjunction with hydrolysis
in regular 16O-rich H2O, yields high resolution FTMS spectra with detection of endogenous FAs
and internal standard-derived FAs as deprotonated carboxylate ions (Figure 1A). We note that this
approach (i.e., full scan FTMS analysis) only allows annotating detected FAs at the “lipid species-level”,
indicating the total number C atoms and double bonds in a particular FA analyte.
Having established that our strategy in principle enables fast and simple monitoring of total
FA levels, we proceeded to evaluate its performance in terms of analytical accuracy. In our initial
assessments we found that especially FA 16:0 and FA 18:0 give rise to high background intensity levels
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(Figures S1 and S2). This analytical caveat prompts poor signal-to-background values for the detection
of endogenous FA 16:0 and FA 18:0, which in turn hampers their accurate and precise quantification.
Importantly, this caveat is common to all total FA analysis methods, including GC-MS-based routines
(Figure S3), and is caused by FA contaminants present even in high-grade organic solvents, glassware
and pipette tips used for sample preparation [28]. Notably, we found that the signal-to-background for
FTMS analysis of FA 16:0 and FA 18:0 in 1 µL of human plasma was 9.9 and 4.3, respectively (Figures
S1 and S2). In comparison, the signal-to-background for GC-MS-based analysis of FAME 16:0 and
FAME 18:0 in 1 µL of human plasma is approximately 3.3 and 1.8, respectively (Figure S3). Hence,
the performance our novel method for monitoring of FA 16:0 and FA 18:0, based on lipid hydrolysis
with regular 16O-rich H2O and FTMS analysis, is comparable to that of GC-MS-based routines.
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Figure 1. Detection of deprot nated fatty acyl (F ) l t s 1 in of high resolution Fourier
transform ass spectrometry (FTMS). (A) e ti i e FT S spectrum of a total FA extract of
human plasma using regular 16O-rich H2O for acid- atalyzed hydrolysis. (B) Negative on mode FTMS
spectrum of a total FA extr ct of human plasma using 18O-enriched H2O for acid-catalyzed hydrolysis.
(C–F) Se ected m/z intervals of the FTMS sp ctrum shown in B. These m/z intervals show baseline
separation of deprotonated FA species with different numbers of double bonds, 18O, 16O, 13C, 12C, 2H
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3.2. Hydrolysis with H218O Improves Signal-to-Background
To minimize, or potentially remove, t r und intensity from FA 16:0 and FA 18:0
we next explored the fficacy of hydrolyzing intact li i ce of 18O-enriched H2O (i.e.,
H218O). We d emed that is procedure should red ce the contribution of ackground by incorporating
a “mass tag” label into endogenous FAs with eith r ne or two 18O atoms, corresponding to inserting
a specific mass offset of 2.0042 and 4.0085, respectively, compared to underivatized, background FA
species having two 16O atoms. Using this strategy, we first found that the unique mass signature of
the 18O atom, and using a resolving power in the order of 400,000 (FWHM at m/z 300) for FTMS
analysis, afforded specific detection of FA species labeled with either one or two 18O atoms with
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baseline separation from isobaric FA molecule having any configuration of 13C, 12C, 2H, 1H and
16O atoms (Figure 1B–F). Notably, baseline separation of isobaric FA analytes can be achieved using
instrumentation with a mass resolution higher than ~95,000 (FWHM at m/z 300). Assessing the FA 16:0
and FA 18:0 background levels after hydrolysis with H218O showed more than a 2.3-fold improvement
in the signal-to-background for detection of endogenous FA 16:0 and FA 18:0, respectively (Figures S1
and S2). As a safeguard for using H218O we also investigated, over a period of 56 days (eight weeks),
whether the incorporated 18O atoms would scramble during sample storage at−20 ◦C. This assessment
demonstrated that 18O-labeled FA analytes are highly stable and do not incorporate 16O atoms upon
storage (Figure S4). Based on these observations, we concluded that acid-catalyzed lipid hydrolysis
with H218O and high resolution FTMS analysis is a feasible and specific strategy for monitoring total
FA levels in human plasma samples.
3.3. Instrument Response Is Independent of Fatty Acyl Chain Length and Double Bond Number
The combined efficiency of ionization and detection of lipid molecules is an important
parameter for accurate and absolute quantification. This efficiency is dependent on numerous
parameters, including the chemistry of the lipid class, the FA chain length and number of
double bonds, the ionization mechanism (i.e., ion source), the type of mass spectrometer and the
acquisition method [11,14].
To examine the instrument response for deprotonated FA analytes, we hydrolyzed and analyzed
a FAME standard mixture with 14 different species in equal amounts (w/v) (where 18:3 and 22:5
are present as two isomers). This evaluation showed that all deprotonated FA analytes produced an
identical instrument response (Figure 2). Importantly, this demonstrates that the instrument response
for detection of deprotonated FA species using nanoelectrospray ionization and FTMS analysis is
practically independent of FA chain length and the number of double bonds, at least for FAs with
chain lengths from 16 to 22. Moreover, this also justifies using the spike of only a single internal
standard (e.g., FA 18:1(+2H7) derived from PE 15:0/18:1(+2H7)) to quantify the wide range of FA
analytes present in human plasma and serum samples.
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Figure 2. Instrument response for detection of deprotonated fatty acyl (FA) analytes is independent
of chain length and number of double bonds. A standard mixture with 14 different NEFA species
present in equal amounts (where FA 18:3 and FA 22:5 are present as two isomers, 18:3n−3 and 18:3n−6,
and 22:5n−3 and 22:5n−6, respectively), was subjected to acid-catalyzed hydrolysis using H218O and
Fourier transform mass spectrometry (FTMS). Data represent average ± SD (n = 3).
3.4. Dynamic Quantification Range of Total Fatty Acyl Analysis by FTMS
Next, we evaluated the dynamic quantification range of our method. To this end, we prepared
a dilution series where the synthetic standard PE 15:0/18:1(+2H7) was titrated relative to a constant
amount of the synthetic standard LPC 16:0(+2H3). This dilution series was spiked into human plasma
samples, which were subjected to direct acid-catalyzed hydrolysis using H218O. The resulting total
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FA extracts were analyzed by 1 min FTMS analysis. To evaluate the dynamic quantification range,
we plotted the intensity ratio of FA 18:1(+2H7) and FA 16:0(+2H3) as a function of their molar ratio
(Figure 3). The response was linear, with a slope value of approximately one across four orders of
magnitude and having a detection limit of approximately 0.9 nM in human plasma (corresponding
to the molar ratio value of 0.0013 in Figure 3). Thus, our method is approximately two orders of
magnitude more sensitive than typical GC-MS-based methods [11]. Based on this result, we conclude
that our novel method affords rapid and highly sensitive quantification of FAs in human plasma.
We note that the instrument response for FA 15:0 was also linear, with a slope value of approximately
one, but only across three orders of magnitude since human plasma contains low amounts of this
odd-chain FA (Figure S5).
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consensus values, and also that the accuracy of our method was in several instances superior to that 
of certain laboratories using GC- or LC-based methods for analysis (Figure 4). In the comparison to 
consensus values, we found that the most abundant FA 18:2 had a subtle difference of −7%. For the 
most abundant monounsaturated FA 16:1 and FA 18:1 the accuracy of quantification differed by 8% 
and 13%, respectively. For polyunsaturated FAs, such as FA 20:4, 22:5 and 22:6, the accuracy of 
quantification differed by −7%, 2% and −22%, respectively. For FA 16:0 and FA 18:0, having the 
Figure 3. Dynamic quantification range of total fatty acyl (FA) analysis. PE 15:0/18:1(+2H7) was titrated
relative to a constant amount of LPC 16:0(+2H3), spiked into 1 µL human plasma and subjected to
acid-catalyzed hydrolysis using H218O. The total FA extracts were analyzed by direct infusion Fourier
transform mass spectrometry (FTMS). The x-axis shows the concentration of FA 18:1(+2H7) relative to
the concentration of FA 16:0(+2H3) (i.e., molar ratio). The y-axis shows the intensity of deprotonated
FA 18:1(+2H7) relative to the intensity of FA 16:0(+2H3). Depicted values derive from two replicate
analyses. The line indicates the linear function with slope 1.
3.5. Accurate Fatty Acyl Quantification by High Resolution FTMS Analysis
To assess the accuracy of our method, we analyzed the NIST human plasma standard reference
material (SRM) 1950. This reference material h s previously been used for compiling consensus
values on the absolute levels of FAs in human plasma and also for comparing the performance of
several laboratories using GC- and LC-based ap roaches for total FA analysis [29]. To bench ark the
perform nce of our method, we subjected the SRM 1950 plasma to acid-catalyzed hydrolysis with
H218O and a alyzed the total FA extracts by irect infusion FTMS analysis. Overall, we found that
estimates of total FA levels by our method were in good agreement with the SRM 1950 consensus
values, and als that the accuracy of our method was in several instances superior to that of certain
laboratories using GC- or LC-based methods for analysis (Figure 4). In the comparison to c nsensus
values, we f und that the most abundant FA 18:2 had a subtle difference of −7%. For the most
abundant monounsaturated FA 16:1 and FA 18:1 the accuracy of quantification differed by 8 and 13%,
respectively. For poly nsaturated F s, such as FA 20:4, 22:5 and 22:6, the accuracy of quantification
differed by −7%, 2% and −22%, respectively. For FA 16:0 and FA 18:0, having the highest background
inte sity (see above), we found that the estimated concentration differed by −37% and −13%. We note
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that this discrepancy is related to the difference in signal-to-background mentioned above (Figures
S1 and S3) and the higher accuracy of estimating the FA background level by our approach. As such,
our method seems to provide a more accurate estimate of the relatively high FA 16:0 background level
than GC-based routines, and using this higher background amount to estimate the endogenous FA
16:0 level yields, by background subtraction, a lower endogenous FA 16:0 concentration than listed in
the SRM 1950 Certificate of Analysis. Overall, based on our detailed assessment of the quantification
accuracy, we conclude that our novel method affords accurate absolute quantification of total FA
levels in human plasma, and its performance is comparable, or at times superior, to that of numerous
laboratories using gold-standard GC- and LC-based routines for total FA analysis.
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Figure 4. Total fatty acyl (FA) levels in human plasma standard reference material (SRM) 1950. Blue
bars represent certified and reference values ± expanded uncertainties (U95%) as listed in the certificate
of analysis for SRM 1950. Grey bars represent medians of average values measured by different
laboratories. The concentrations measured by the different laboratories are shown as individual data
points. Green bars represent the average concentration ± SD (n = 4) measured by Fourier transform
mass spectrometry (FTMS) of plasma samples hydrolyzed using sulfuric acid in acetonitrile/H218O.
3.6. Total Fatty Acyl Analysis by FTMS Is Precise and Applicable for Routine Analysis
Next, we determined the analytical precision of our novel method for total FA quantification in
human plasma samples. To this end, we used two types of plasma samples: i) a pooled plasma sample
from fasted normoinsulinemic subjects having a total FA concentration of 11.5 mM (normal lipid
level), and ii) a pooled plasma sample from 6 h postprandial hyperinsulinemic subjects having a total
FA co centration of 24.8 mM (high lipid level). To de ermine the intra-day and nter-day precision,
we independently prepared and analyzed five tot l FA ex racts of these two ypes of plasma samples.
Th s sample preparati n and naly is was repeated on th ee independent days. The precision on
individual days (intra-day precision) showed a coefficient f variation (CV) always below 8.6% and
11.3% for the normal and high lipid l vel samples, r spectively (Table 1). The inter-day (day-to-day)
recision showed CV v lues always bel w 11.1%. The e perform nce charact ristics demonstrate that
our novel method for total FA a alysis, bas d on acid-catalyzed hydrolysis with H218O and direct
FTMS analysis, is similar t that of gold-standard approaches using FAME d rivatization and GC-based
analysis [11], and also to that of routine methods used for quantification of other clinically-relevant
lipid molecules [25,30,31].
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Table 1. Intra-day and inter-day precision of total FA analysis in human plasma samples.
Intra-Day Inter-Day
Day 1 (n = 5) Day 2 (n = 5) Day 3 (n = 5) (n= 3 × 5)
Analyte Insulin µM ± SD CV (%) µM ± SD CV (%) µM ± SD CV (%) µM ± SD CV (%)
FA 16:0
Normal 1852 ± 103 5.5 2085 ± 179 8.6 2028 ± 105 5.2 1988 ± 161 8.1
High 4239 ± 294 6.9 3798 ± 288 7.6 4373 ± 218 5.0 4137 ± 356 8.6
FA 18:1
Normal 2898 ± 54 1.9 3132 ± 156 5.0 3130 ± 183 5.8 3053 ± 174 5.7
High 10859 ±534 4.9 9618 ± 279 2.9
11114 ±
508 4.6
10531 ±
797 7.6
FA 18:2
Normal 3404 ± 133 3.9 3734 ± 192 5.1 3765 ± 162 4.3 3634 ± 227 6.2
High 3442 ± 275 8.0 * 3031 ±102 3.4 3640 ± 412 11.3 3396 ± 378 11.1
FA 20:4
Normal 920 ± 24 2.6 948 ± 26 2.8 998 ± 80 8.0 955 ± 58 6.0
High 1728 ± 95 5.5 1504 ± 56 3.7 1750 ± 111 6.4 1661 ± 142 8.6
FA 20:5
Normal 108 ± 3.6 3.3 115 ± 3.1 2.7 121 ± 10 8.6 115 ± 8.2 7.1
High 188 ± 8.9 4.7 165 ± 6.5 3.9 194 ± 14 7.0 182 ± 16 8.8
FA 22:5
Normal 73 ± 3.0 4.1 76 ± 1.8 2.4 82 ± 5.9 7.2 77 ± 5.3 6.8
High 146 ± 8.5 5.8 123 ± 4.4 3.6 147 ± 9.9 6.7 139 ± 13 9.6
FA 22:6
Normal 197 ± 5.2 2.7 205 ± 5.3 2.6 216 ± 16 7.4 206 ± 12 6.0
High 163 ± 8.5 5.2 141 ± 6.4 4.5 167 ± 14 8.6 157 ± 15 9.7
Values are average fatty acyl (FA) concentrations (µM) in human plasma from a fasted normoinsulinemic subject
(representing normal total lipid level) and a 6 h postprandial hyperinsulinemic subject (representing high total lipid
level). Plasma samples were hydrolyzed in the presence of H218O to assess intra-day precision. Acid-catalyzed
hydrolysis of normal and high lipid level samples was done on three consecutive days to assess inter-day precision.
* one value out of five for “FA 18:2 Day 2 High insulin” has been removed after outlier correction. CV: coefficient
of variation
3.7. Lipotyping of Human Serum Samples by Total Fatty Acyl Analysis
Next, we evaluated the efficacy of our method for determining differences in total FA levels
in samples from humans subjected to dietary interventions. For this purpose, we used the NIST
SRM 2378 [32], a reference material of pooled human serum from three groups of healthy individuals:
(i) subjects supplemented with fish oil (enriched in eicosapentaenoic acid, FA 20:5, and docosahexaenoic
acid, FA 22:6), (ii) subjects supplemented with flaxseed oil (enriched in linoleic acid, FA 18:2), (iii) and
control subjects (no dietary intervention). Total FA analysis of these serum samples demonstrated again
that our method is accurate and capable of reproducing expected total FA levels listed in the Certificate
of Analysis (Table S1). Here the main differences were found for FA 16:0 and FA 20:4, which were
in averaged under-estimated by 40% and over-estimated by 42%, respectively. Furthermore, our
results also showed that serum from subjects supplemented with fish oil had increased levels of
polyunsaturated FAs, including up to 5-fold and 2-fold higher FA 20:5 and FA 22:6 concentrations,
respectively, compared to control serum (Figure 5). In addition, we also observed a 1.4-fold higher
concentration of FA 18:1 in individuals supplemented with flaxseed oil. Taken together, these results
consolidate that our novel total FA analysis method supports accurate monitoring of differences in FA
composition in fasted human blood samples and is applicable for personalized lipotyping similar to
GC- and LC-based approaches.
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Figure 5. Total fatty acyl (FA) levels in serum from human subjects supplemented with fish oil or
flaxseed oil, and subjects receiving no dietary intervention (SRM 2378). Serum lipids were subjected
to acid-catalyzed hydrolyzed with H218O and analyzed by high resolution Fourier transform mass
spectrometry (FTMS). Data represent average ± SD (n = 4, independently prepared and analyzed
samples). * p < 0.001 (unpaired, two-sided Student’s t-test with comparison to “No supplement”).
3.8. Q antitative Analysis of Stable Isotope-Labeled Fatty Acyls in Human Plasma
Based on the analytical capability of our high resolution Orbitrap-based mass spectrometer to
baseline-separate individual FAs having distinct composition of isotopologues (e.g., 12C, 13C, 1H,
2H, 16O and 18O atoms), we next decided to explore whether our method would also be applicable
for metabolic s udies in humans. Such studies are c mmonly done by feedin human subjects
with stable isotope-labeled fatty aci s, sampling blood plasma at defined time points after intake,
and performing time series analysis of tracer in rporation using GC-MS [22,33]. To evaluate the
performance of our platform for such studies, we analyzed plasma sa ples from ten individuals,
classified as normoinsulinemic (n = 5) and hyperinsulinemic (n = 5). The plasma samples were coll c ed
at baseline (time point 0 h) and 6 h after he individuals had consumed a mixed meal containing 200
mg o 13C16-labeled palmitic a id (i.e., FA 16:0(+13C16)) [22]. Notably, previous analy is has hown
that after 6 h the plasma pool of FA 16:0(+13C16) is p imarily present as non-e terified fatty acid (~1
µM) a d incorporated into triacylglycerol (~2 µM) [22].
T tal FA n lysis using acid-c talyzed H218O hydrolysi and 1 min of FTMS analysis how
that deprotonated FA 16:0(+13C16) labeled with on r two 18O atoms were detected in all plasma
samples collected at the 6 h time point and not at baseline (Figure 6). This shows th t our method is
specific and effectively free of noise for monitoring the uptake of FA 16:0(+13C16) into blood l .
We also searched the mass spectral data for whether any metabolic product of FA 16:0(+13C16) c uld
be detected, including FA 16:1(+13C16), FA 18:0(+13C16) and FA 18:1(+13C16). However, n ne of these
m t b lit s ould be detected, potentially du to the li it of detection of ur method. The total
FA 16:0(+13C16) concentration in plasma from the normoinsulinemic and hyperinsulinemic subjects
was estimated to 4.9 ± 2.4 µM and 5.4 ± 3.1 µM, respectively. Statistical analysis showed no
significant differ ce in the tot l FA 16:0(+13C16) concentration (unpaired, two-sided t-test, p-value =
0.7). Importantly, this result corroborates the previous findings by Pr mfalk et al. (2016) reporting a
similar total concentr tion of FA 16:0(+13C16) in the plasma samples and no diff rence between the
normoinsulinemic and hype insulinemic subjects at the 6 h time point. However, the previous study
did find a signifi a t difference in the temporal profile of non-esterified FA 16:0(+13C16) level between
the two groups of subjects.
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Figure 6. Specific monitoring of fatty acyl (FA) 16:0(+13C16) in human plasma by high resolution Fourier
transform mass spectrometry (FTMS). Representative FTMS spectra of plasma from a normoinsulinemic
subject at 0 h (baseline) and 6 h after intake of FA 16:0(+13C16). Plasma samples were subjected to
acid-catalyzed hydrolysis with H218O and analyzed by high resolution FTMS analysis. Indicated FA
analytes are detected as deprotonated carboxylate anions.
Next, we investigated whether the plasma concentration of other (unlabeled) FA species showed
any major differences across the two time points and between the two groups of subjects. Statistical
analysis of time-dependent changes in absolute FA concentrations within each group showed that
only three FAs changed significantly; FA 14:0 (in both groups), FA 18:1 (only in normoinsulinemic
subjects) and FA 16:0(+13C16) (in both groups) (paired, two-sided t-test, p-value < 0.05). No significant
differences were found between the two groups (unpaired, two-sided t-test, p-value < 0.05). Notably,
this relatively low frequency of significant differences correlates to a relatively high variance in total
FA concentration among all the samples (Figure S6).
As an alternative approach to pinpoint differences, we transformed the concentration data to
relative mol%, thereby reducing the influence of variations in the total FA concentration. Repeating
the statistical analysis revealed that the relative proportions of 18 out of 31 monitored FA species
change significantly in either of the two groups (Figure 7) (paired, two-sided t-test, p-value < 0.05).
The three common and most significantly changing FAs were FA 16:1, FA 14:0 and FA 18:3, all of which
were reduced 6 h after food intake. The analysis also pinpointed a specific subset of polyunsaturated
FAs that are significantly changing only in the normoinsulinemic subjects (i.e., FA 22:4, FA 20:3, FA
22:5, FA 18:2, and FA 16:2), and four distinct FA species, primarily saturated and monounsaturated
very long chain FA species, FA 24:1, FA 24:0, FA 22:0, and FA 12:0, that are significantly changing
only in the hyperinsulinemic subjects. Finally, the statistical analysis of differences between the
normoinsulinemic and hyperinsulinemic subjects revealed that only the relative change of FA 16:1 is
statistically significant (unpaired, two-sided t-test, p-value = 0.04). Here, the temporal reduction in the
FA 16:1 level is 1.5-fold higher in normoinsulinemic as compared to hyperinsulinemic subjects. Taken
together, these results highlight that our new method lends itself to also lipid metabolic studies in
humans, and other mammals, with the ability to reproducibly and specifically monitor incorporation
of stable isotope-labeled FA tracers as well as changes in steady-state FA levels following food intake.
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spectrometry (FTMS). Interconnected data points in box plots represent repeated measurements 
from five individuals within each group. p-values are based on paired, two-sided t-tests of 
differences within each subject group. q-values are based on unpaired, two-sided t-tests of 
time-dependent differences between the two groups. p- and q-values below 0.05 are considered 
statistically significant. 
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FA tracers in humans. In particular, our method demonstrated that the total concentration of 
13C16-labled FA 16:0 in plasma 6 h after intake was similar in normoinsulinemic and 
hyperinsulinemic subjects. In contrast, the analysis of steady-state FA levels showed that a subset of 
polyunsaturated FAs, including FA 18:2, FA 20:3, FA 22:4 and FA 22:5, were significantly reduced 
only in normoinsulinemic subjects and not changed in hyperinsulinemic subjects. Conversely, we 
found a subset of very long chain FA species, including FA 24:1, FA 24:0 and FA 22:0, that were 
significantly reduced only in the hyperinsulinemic subjects. These changes corroborate the notions 
that polyunsaturated FAs have a positive impact on metabolic health [34] and that very long chain 
Figure 7. Total fatty acyl (FA) profiles of normoinsulinemic (NI) and hyperinsulinemic (HI) subjects at
0 h (baseline) and 6 h after intake of FA 16:0(+13C16). Plasma lipids were subjected to acid-catalyzed
hydrolysis with H218O and analyzed by high resolution Fourier transform mass spectrometry (FTMS).
Interconnected data points in box plots represent repeated measurements from five individuals within
each group. p-values are based on paired, two-sided t-tests of differences within each subject group.
q-values are based on unpaired, two-sided t-tests of time-dependent differences between the two
groups. p- and q-values below 0.05 are considered statistically significant.
4. Conclusions
Here, we described the development and validation of a novel method that supports fast,
precise, and accurate absolute quantification of tot l FA levels in human plasma and serum samples.
The method uses acid-catalyzed hydrolysis of intact lipids in the presence of 18O-labeled H2O
(i.e., H218O) and therethrough the liberation of FA chains as 18O-labeled a alytes. These “mass-tagged”
FA analytes can be specifically detected, with improved signal-to-background, using automated
chip-b sed nanoel ctrospray ionization and only 1 min of high resolution FTMS analysis on an
Orbitr p Fusion mass spectrometer. We demonstrate that our novel method has similar, or improved,
analytical perf rmance in t rms of accuracy and precision compared t numerous laboratories using
gold-standard GC-based methods for total FA an lysis (Figure 4). We deem that our n vel thod
should prove hi hly useful for labor tories equipped with high resolution mass sp ctro eters,
b t lacking access to GC-based instrumentation.
We also demonstrate that our method is applicable for specific tracking of stable isotope-labeled FA
tracers in humans. In p rticular, our method demonstrated that the total concentr tion of 13C16-labl
16:0 in plasma 6 h after intake was similar in normoinsulinemic and yperinsuli emic subjects.
In contrast, the analysis of steady-state FA levels showed that a subset of polyunsaturated FAs,
including FA 18:2, FA 20:3, FA 22:4 nd FA 22:5, were significantly reduced only in normoins lin mic
subject and not changed in hyperinsulinemic subjects. Conversely, we found a subset of very long
chain FA species, including FA 24:1, FA 24:0 and FA 22:0, that were significantly reduced only in th
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hyperinsulinemic subjects. These changes corroborate the notions that polyunsaturated FAs have a
positive impact on metabolic health [34] and that very long chain FAs, especially when incorporated
into sphingolipids, are associated with increased cardiovascular risk [35,36]. We note, however, that
these results have only been obtained by analysis of a relatively low number of subjects (n = 5),
and that analysis of a larger cohort of subjects, and with more time points, should be performed
in order to increase the statistical power of our results. It is tempting to propose that such studies
could in future be performed using not only a single FA tracer, but instead a mixture of stable
isotope-labeled FA tracers, e.g., FA 18:2n−6, FA 18:3n−3 and FA 16:0, which will simultaneously
provide insights into the metabolic trajectories of a wider range of FA species under normoinsulinemic
and hyperinsulinemic conditions.
We note that our method does not provide the same level of structural resolution as some of the
more time-consuming GC-MS-based approaches. However, it does strike a unique balance between
analytical speed and FA molecule coverage. As such, gold-standard GC-MS-based approaches are able
to monitor around 44 FAME species using an analysis time of 15 min, i.e., effectively detecting 2.9
FAMEs per minute of analysis [24]. In comparison, our novel approach supports monitoring of at least
31 FA species by 1 min of analysis. We note that, if needed, this analysis time can be reduced to 0.5 min
per sample without jeopardizing the FA coverage and the analytical performance. Furthermore, our
method can also be adapted, through increased analysis time, to record MS2 scans with diagnostic
radical FA fragment ions that identify double bond-positional isomers, at least for monounsaturated
FA species (e.g., FA 18:1(9) and FA 18:1(11)) [37]. Further developments of this orthogonal approach,
for example by combining specialized gas-phase dissociation mechanisms such as OzID [38], should
enable the specific detection and quantification of many more FA double bond positional isomers.
It is tempting to propose that such technology, if successfully implemented, could potentially be the
beginning of making GC-based platforms for routine analysis of total FA levels obsolete.
Finally, our novel method is not only restricted to total FA analysis of human blood samples.
We note that our generic, high-throughput method can also be used in many other fields of research.
These include routine analysis for assessing food quality, biotechnological application aimed at
optimizing oil production in plants and microorganisms, and for biochemical assays of lipid enzymatic
activities (e.g., fatty acid synthases, desaturases and elongases). We also note that the use of H218O
can be replaced with regular 16O-rich H2O to reduce costs, although this will lead to less accurate
estimates of total FA 16:0 and 18:0 levels (1 mL H218O for 125 samples costs approx. 88 Euro at the
present). Finally, we note that our novel method can also serve as a quality control routine to accurately
quantify and verify the concentrations of commercially available lipid standards used for absolute
quantification in global lipidomics [21,26,35,39–41], instead of using cumbersome colorimetric assays
that require high amounts of material to quantify, for example, glycerophospholipids.
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